Mebolazine

Mebolazine

Mebolazine (also known as Dimethazine, Dymethazine, or DMZ) is a synthetic anabolic steroid that is used by athletes and bodybuilders for its potential to increase muscle mass and strength. It is a derivative of Dianabol, but with a different structure that results in a slightly different effect on the body.

History

Mebolazine was first described in the scientific literature in the 1960s. It was developed by the pharmaceutical company Syntex, which was also responsible for the creation of several other anabolic steroids, including Oxymetholone and Methasterone.

Pharmacology

Mebolazine is a prodrug that is converted in the body to two active forms of the steroid Methasterone. These active forms have a high affinity for the androgen receptor, which is the primary mechanism by which anabolic steroids exert their effects.

The steroid has a high anabolic to androgenic ratio, meaning it has a strong effect on muscle growth with fewer of the side effects typically associated with androgenic steroids. However, like all anabolic steroids, Mebolazine can have serious side effects, including liver damage, cardiovascular disease, and changes in mood and behavior.

Legal Status

In many countries, including the United States, Mebolazine is classified as a controlled substance and is illegal to possess without a prescription. It is also banned by most sports organizations due to its potential to give athletes an unfair advantage.

See Also

• Anabolic steroid
• Dianabol
• Methasterone
• Oxymetholone
• Syntex

References

   This article is a Anabolic steroid-related stub. You can help WikiMD by expanding it!

This article is a stub related to pharmacology. You can help WikiMD by expanding it!